# Polymenorrhea (Frequent Periods)

- Category: acute
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Egyptian National Drug Formulary - Endocrine System Drugs 2024, norethisterone (norethindrone) monograph (endocrine.pdf page index 125, printed p112) · Microgynon 30 (ethinylestradiol 30 mcg + levonorgestrel 150 mcg) SmPC sections 4.2-4.4 (eMC product 1130) · SmPC sections 4.1 and 4.2, https://www.medicines.org.uk/emc/product/1130/smpc · Tranexamic Acid 500 mg Tablets SmPC section 4.2 (eMC product 14622) · Mikes BA, Vadakekut ES, Sparzak PB. Abnormal Uterine Bleeding. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2025 Feb 21. Bookshelf ID: NBK532913; PMID: 30422508.
- Verified date: 2026-08

## Verified against

- Egyptian National Drug Formulary - Endocrine System Drugs 2024, norethisterone (norethindrone) monograph (endocrine.pdf page index 125, printed p112)
- SmPC section 4.2, https://www.medicines.org.uk/emc/product/14622/smpc
- SmPC sections 4.1 and 4.2, https://www.medicines.org.uk/emc/product/1130/smpc
- Mikes BA, Vadakekut ES, Sparzak PB. Abnormal Uterine Bleeding. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2025 Feb 21. Bookshelf ID: NBK532913; PMID: 30422508.

## Treatment metadata

- Norethisterone — 5 mg — oral.solid
- Tranexamic acid — 500 mg — oral.solid

## Complete treatment card

```text
POLYMENORRHEA (FREQUENT PERIODS)
Sources: Egyptian National Drug Formulary - Endocrine System Drugs 2024, norethisterone
         (norethindrone) monograph (endocrine.pdf page index 125, printed p112) · Microgynon 30
         (ethinylestradiol 30 mcg + levonorgestrel 150 mcg) SmPC sections 4.2-4.4 (eMC product 1130)
         · SmPC sections 4.1 and 4.2, https://www.medicines.org.uk/emc/product/1130/smpc ·
         Tranexamic Acid 500 mg Tablets SmPC section 4.2 (eMC product 14622) · Mikes BA, Vadakekut
         ES, Sparzak PB. Abnormal Uterine Bleeding. In: StatPearls [Internet]. Treasure Island (FL):
         StatPearls Publishing; 2026 Jan-. Updated 2025 Feb 21. Bookshelf ID: NBK532913; PMID:
         30422508.
Review status: REVIEWED against 4 sources listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (8)
    - Bleeding is called frequent when the cycle interval is <24 days  [bleeding]
    - Cycle timing counts as irregular once it varies >20 days
    - A period lasting >8 days is prolonged
    - Heavy loss is >80 mL and light is <5 mL of blood loss
    - Since volume cannot be measured, ask how often pads are changed by day and by night, and about
      clot size
    - Ask separately about bleeding between periods and after sex  [abnormal uterine bleeding]
    - Ask too about weight loss, pain, discharge and bowel or bladder trouble  [weight loss]
    - Ask what contraception is in use and about any past sexually transmitted infection
  SIGNS - what you find (8)
    - Look first for instability: a postural drop in pressure, or a fast pulse
    - Skin clues to anaemia or a clotting disorder are pallor, petechiae and bruising  [anaemia ·
      bruising · pallor · petechiae]
    - Feel the thyroid for swelling or tenderness
    - Excess hair growth, clitoromegaly or acne point to androgen excess  [acne · excess hair]
    - Moon face, odd fat distribution and striae raise Cushing syndrome  [stretch marks]
    - Palpate the abdomen for a pelvic or an abdominal mass  [abdominal mass]
    - Both a speculum and a bimanual examination belong in the pelvic assessment
    - In an adolescent, check the bleeding fits her sexual maturity by Tanner stage  [bleeding]
  TESTS (12)
    - Exclude pregnancy by urine or serum hCG and send a full blood count for anaemia and low
      platelets
    - Test thyroid function where there are thyroid features, or where nothing else explains the
      bleeding
    - Keep prolactin, androgen and oestrogen assays for a suspected endocrine cause such as
      anovulation
    - First-line clotting screen is a platelet count with prothrombin and partial thromboplastin
      times
    - A normal clotting screen does not exclude von Willebrand disease, so haematology input is
      often needed
    - Screen for a bleeding disorder when menses run ≥7 days with gushes, or soaking a tampon in 2
      hours or less
    - Screen also after anaemia needing treatment, a relative with a bleeding disorder, or heavy
      loss at extraction, delivery or surgery
    - Ferritin measures iron stores, and inflammation can hold it normal despite anaemia
    - Ultrasound, transvaginal or transabdominal, is the first imaging and finds polyps, adenomyosis
      or fibroids
    - Sample the endometrium from 45 years or older, because cancer risk climbs with age
    - Sample younger women too when bleeding persists, oestrogen was unopposed, or drug treatment
      failed
    - Symptoms persisting after a normal biopsy call for hysteroscopy, as blind sampling misses
      focal lesions
  IF NOT THIS - what else fits (9)
    - Blood from the urinary or the bowel tract can be mistaken for menstrual loss
    - Vulval growth, benign or malignant
    - Vaginal growth, infection, vaginitis, cancer, trauma or a retained foreign body
    - Cervical growth, a sexually transmitted infection, or cervical cancer
    - Pelvic inflammatory disease or malignancy of the tubes and ovaries
    - Urinary tract infection or urinary tract cancer
    - Inflammatory bowel disease, or Behcet syndrome
    - Pregnancy itself, miscarriage, ectopic pregnancy or placenta praevia
    - Causes arising in the uterine body are grouped by the PALM-COEIN acronym
  Source  StatPearls "Abnormal Uterine Bleeding" - disease-level clinical article
  Status  traced to the source above

1. NORETHISTERONE                                         [2nd line]
   Adult    Acute bleed: 20 mg by mouth three times daily for 7 days (StatPearls, Abnormal Uterine
            Bleeding NBK532913, acute AUB progestin-only option). The Egyptian National Drug
            Formulary gives 5 mg by mouth three times daily for 10 days for the same indication,
            with bleeding usually stopping within 48 hours. Then, to prevent recurrence: 5 mg by
            mouth twice daily from day 19 to day 26 of each of the next two cycles (Egyptian
            National Drug Formulary). x 7 days for the acute course (StatPearls) or 10 days
            (Egyptian formulary), then the day 19 to day 26 course in each of the two following
            cycles
   Peds     The formulary gives adult dosing only; no paediatric or adolescent dose is stated in
            this monograph.
   Source   StatPearls, Abnormal Uterine Bleeding (NBK532913), acute AUB progestin-only option
            (lead); Egyptian National Drug Formulary - Endocrine System Drugs 2024, norethisterone
            (norethindrone) monograph (endocrine.pdf page index 125, printed p112)
   Why      Cyclical progestogen imposes a normal-length cycle on frequent periods; a standard
            alternative when the combined pill is unsuitable.
   Caution  The two sources disagree four-fold on the acute dose: StatPearls gives 20 mg three times
            daily for 7 days, the Egyptian formulary 5 mg three times daily for 10 days. The
            international figure leads here per the app's source policy; both are printed.
            Evaluate abnormal bleeding that persists or is severe before repeating courses.
            Contraindicated in pregnancy, in current or past deep vein thrombosis or pulmonary
            embolism, in hepatic impairment or disease, and in undiagnosed abnormal genital
            bleeding.
            Alternative when a combined pill is contraindicated or contraception is not wanted; this
            cyclical regimen is NOT reliably contraceptive.
            Never combine with tranexamic acid - listed as a contraindicated (Risk X) combination in
            the Egyptian formulary.
            Side effects include bloating, weight gain, mood change, and breast tenderness.
            Refer to gynaecology if the cycle has not regularised after 3 cycles, or if
            intermenstrual/postcoital/postmenopausal bleeding appears.
   Egypt    CIDOLUT NOR 5 MG 20 TABS.        CID                 36.00 EGP (1.80/unit)
            CIDOLUT NOR 5 MG 30 TABS.        CID                 57.00 EGP (1.90/unit)
            STERONATE 5 MG 20 TABS.          HI-PHARM            56.00 EGP (2.80/unit)

2. TRANEXAMIC ACID                                        [3rd line]
   Adult    1000 mg (2 tabs) PO TID during menstruation (max 4 g/day, up to 4 days). x up to 4 days
            per cycle; continue cycle-to-cycle for as long as it remains beneficial
   Peds     This should be calculated according to body weight at 25 mg /kg per dose.
   Source   SmPC section 4.2, https://www.medicines.org.uk/emc/product/14622/smpc
   Why      Reduces blood loss if the frequent cycles are also heavy; does not lengthen the cycle
            interval itself.
   Caution  Only needed if the frequent cycles are also heavy - it does not lengthen the cycle
            interval, only reduces blood loss during a bleed.
            Contraindicated in active or past venous/arterial thromboembolism.
            Any postmenopausal bleeding needs urgent referral, not this drug.
            Check a full blood count if bleeding is heavy or prolonged; treat confirmed iron
            deficiency separately.
   Egypt    TREXAM 500 MG 20 TABS.           MEMPHIS             24.00 EGP (1.20/unit)
            TRANEX 500 MG 30 TABS.           EGPI > ABBOTT      117.00 EGP (3.90/unit)
            KAPRON 500 MG 20 F.C.TABS.       AMOUN              110.00 EGP (5.50/unit)
            SAVIBLEED 500 MG 20 F.C.TABS.    MARCYRL PHARM...   110.00 EGP (5.50/unit)

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
